Stocks TelegraphStocks Telegraph
Stock Ideas

TRVI Stock Analyst Ratings, Estimated Earnings and Price Targets

NASDAQ : TRVI

Trevi Therapeutics

$14.21
-0.065-0.46%
Open: 10:35 AM
58.29
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

TRVI Stock 12 Month Analyst Forecast

According to evaluations from 18 analysts over the past year, the consensus analyst rating for TRVI stock is "Buy". The average price target based on the past year stands at $20.78, with estimates ranging from $16.00 to $27.00.

Eps Overview

Growth Next 5yrs
-9.46%
Last Quarter
- $0.08
Past Year
- $0.37
Growth Past 5yrs
27.09%
Next Quarter
- $0.10
Estimate Next Year
- $33.15

Consensus Rating

Loading...

Consensus Price Target

Highest Price Target

$27.00

102.55% Upside

Mean Price Target

$20.78

55.87% Upside

Lowest Price Target

$16.00

20.03% Upside

Recent Analyst Ratings

Upgrades, Downgrades, New Coverage

Last Updated On Mar 19, 2026

Actual EPS vs Estimated EPS

TRVI Earnings Per Share (EPS) History

According to financial reports, TRVI (NYSE: TRVI) reported an actual EPS of $-0.08 for the quarter ending on Nov 13, 2025, compared to an estimated $-0.1, resulting in a -20.00% surprise. In the prior quarter (Aug 07, 2025), TRVI recorded an actual EPS of $-0.09 with a -10.00% surprise. See TRVI's full earnings history.

Earnings History

EPS Surprise Factor Analysis

TRVI has experienced notable EPS surprises, with the latest quarter ending Nov 13, 2025 showing a -20.00% miss. Previously, the quarter ending Aug 07, 2025 recorded a -10.00% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.

Report DateActualForecastSurprise Factor
Nov 13, 2025-0.08-0.1-20.00%
Aug 07, 2025-0.09-0.1-10.00%
May 08, 2025-0.09-0.13-30.77%
Mar 18, 2025-0.11-0.12-8.33%
Nov 06, 2024-0.13-0.12+8.33%
Aug 08, 2024-0.12-0.11+9.09%

After EPS Prices

TRVI stock frequently reacts to earnings reports. Following the Nov 13, 2025 earnings, the share price saw a 3.40% rise before closing. On the 7th day after the report, TRVI shares recorded a -0.44% decline. Analyze historical TRVI stock performance post-earnings.

Earning DateBefore EPS ChangeNext Day Closing Price7th Day Closing Price
Nov 13, 2025$11.85+3.40%$11.37-0.79%$11.41-0.44%
Aug 07, 2025$7.27-0.41%$7.42+1.64%$7.45+2.05%
May 08, 2025$6.65+0.76%$6.600$6.49-1.67%
Mar 18, 2025$6.54-0.30%$6.81+3.81%$6.53-0.46%
Nov 06, 2024$3.02-2.58%$2.90-6.45%$2.75-11.29%
Aug 08, 2024$2.59-7.50%$2.86+2.14%$2.97+6.07%

Frequently Asked Questions

Is TRVI stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given TRVI stock an average recommendation of Buy. 18 analysts have given their ratings to TRVI out of which 7 analysts have given strong buy call, 11 analysts have given buy call, 0 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $20.78 gives the stock implied upside of roughly 55.87% over the next year or so.
What have analysts suggested for TRVI highest price target?
Analysts suggest TRVI's stock price would rise to a high of $27.00.
What is the lowest price target analysts expect for TRVI over the next year?
Within the next 12 months, analysts predict the TRVI stock price could move to $16.00.
What is the average target price for TRVI?
TRVI stock has an average analyst estimate of $20.78.
At its current price, how far is TRVI from its average target price?
TRVI shares are currently trading 55.87% above this price target.
What were TRVI’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.08 versus consensus estimates of - $0.10, and above the comparable year-ago quarter’s EPS of - $0.13.
What are the current estimates for quarterly and annual earnings per share?
TRVI's forecasts by analysts estimating quarterly EPS at - $0.10 and - $33.15 for the whole year.
What has TRVI's growth been in the past five years and what is expected in the next five years?
The analysts have projected -9.46% EPS growth for TRVI in the next five years, compared to growth rates of 27.09% in the past five years.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings CalendarStocks Watchlist
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph